Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, Acute Myelogenous”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03454984
What this trial is testing

SGI-110 and Donor Lymphocyte Infusions (DLI) After Allogeneic Stem Cell Transplantation

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid Leukemia
Groupe Francophone des Myelodysplasies 40
Large-scale testing (Phase 3)Study completedNCT00482833
What this trial is testing

Phase III Trial in Acute Promyelocytic Leukemia Patients

Who this might be right for
Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 276
Early research (Phase 1)Looking for participantsNCT06609928
What this trial is testing

FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy for Treating Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Recurrent Childhood Acute Myeloid LeukemiaRefractory Childhood Acute Myeloid Leukemia
Fred Hutchinson Cancer Center 12
Early research (Phase 1)Study completedNCT05775406
What this trial is testing

Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors

Who this might be right for
Myeloid MalignanciesAcute Lymphocytic LeukemiaLymphomas+1 more
Kymera Therapeutics, Inc. 52
Testing effectiveness (Phase 2)Study completedNCT00488592
What this trial is testing

Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers

Who this might be right for
Myelodysplastic Syndrome (MDS)Acute Myeloid Leukemia (AML)Chronic Myeloid Leukemia (CML)
National Heart, Lung, and Blood Institute (NHLBI) 10
Testing effectiveness (Phase 2)Study completedNCT00602771
What this trial is testing

Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+14 more
National Cancer Institute (NCI) 84
Not applicableStudy completedNCT01150058
What this trial is testing

Drug Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 40
Early research (Phase 1)Not Yet RecruitingNCT07722767
What this trial is testing

A Phase 1b Study of CLN-049 in Combination With Azacitidine and Venetoclax in AML Patients

Who this might be right for
AML (Acute Myeloid Leukemia)
Cullinan Therapeutics Inc. 90
Testing effectiveness (Phase 2)Study completedNCT00357565
What this trial is testing

Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia

Who this might be right for
LeukemiaMyelodysplastic SyndromesChildhood Acute Myeloid Leukemia in Remission+10 more
Masonic Cancer Center, University of Minnesota 34
Not applicableStudy completedNCT01611298
What this trial is testing

Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaChronic Myelogenous Leukemia+3 more
Robert Krance 7
Large-scale testing (Phase 3)Study completedNCT00822393
What this trial is testing

Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
medac GmbH 570
Not applicableStudy completedNCT03894852
What this trial is testing

SRSF2 Gene Mutation in Patients With t-MDS/AML

Who this might be right for
Therapy Related Myelodysplastic Syndrome and Therapy Related Acute Myeloid Leukemia
Zeinab Albadry Mohammed Zahran 139
Testing effectiveness (Phase 2)Active Not RecruitingNCT04214249
What this trial is testing

BLAST MRD AML-1: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 1- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Intensive Chemotherapy as Frontline Therapy in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia Post Cytotoxic Therapy+1 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT01385787
What this trial is testing

MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Center for International Blood and Marrow Transplant Research 150
Testing effectiveness (Phase 2)Ended earlyNCT03576547
What this trial is testing

Venetoclax, Ponatinib, and Dexamethasone in Participants With Philadelphia Chromosome or BCR-ABL Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia

Who this might be right for
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositivePhiladelphia Chromosome PositiveRecurrent Acute Lymphoblastic Leukemia+4 more
M.D. Anderson Cancer Center 9
Large-scale testing (Phase 3)UnknownNCT05457361
What this trial is testing

VAH Versus VA for Salvage Therapy of R/R-AML

Who this might be right for
Venetoclax Combined With Azacitidine Plus HomoharringtonineVenetoclax Combined With Azacitidine
Nanfang Hospital, Southern Medical University 162
Large-scale testing (Phase 3)WithdrawnNCT00006451
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Leukemia

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma
Masonic Cancer Center, University of Minnesota
Testing effectiveness (Phase 2)Study completedNCT00045942
What this trial is testing

PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Novartis Pharmaceuticals 144
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06667973
What this trial is testing

Efficacy of Gilteritinib in Combination With FLAI as Induction Therapy of FLT3-positive Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaFLT3 Gene MutationAdult AML+1 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 80
Large-scale testing (Phase 3)UnknownNCT01145846
What this trial is testing

Idarubicin Versus High Dose Daunorubicin in Acute Myelogenous Leukemia (AML)

Who this might be right for
Acute Myelogenous Leukemia
Cooperative Study Group A for Hematology 316
Next Page
49